Forte Biosciences
IPOPublic · Dallas, United States · Founded 2017 · $53.0M raised
- Headquarters
- Dallas, Texas
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- fortebiorx.com
- Total Funding
- $53.0M
- Last Round
- $53.0M Corporate RoundNov 2024
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company developing live biotherapeutics for autoimmune and inflammatory skin diseases.
Summary
Forte Biosciences is a Biotech company based in Dallas, United States, founded in 2017. It has raised $53.0M in total across 1 round, most recently a $53.0M Corporate Round round in Nov 2024. Investors include OrbiMed and BVF Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...